{"transactions":[{"id":1699566,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":95804,"kind":"organization","name":"Falcon Fund 2 Holding Company, L.P.","position":1,"cik":"0001817718","reported_name":"Falcon Fund 2 Holding Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock, par value $0.001 per share","published_at":"2023-12-27T16:47:43.000Z","date":"2023-12-22","kind":"exercise","planned":false,"acquired":false,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share (\"Series B Preferred Stock\"), of MiMedx Group, Inc. (the \"Issuer\") held by Falcon Fund 2 Holding Company, L.P. (the \"Reporting Person\"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share (\"Common Stock\"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share (\"Series B Preferred Stock\"), of MiMedx Group, Inc. (the \"Issuer\") held by Falcon Fund 2 Holding Company, L.P. (the \"Reporting Person\"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share (\"Common Stock\"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share (\"Series B Preferred Stock\"), of MiMedx Group, Inc. (the \"Issuer\") held by Falcon Fund 2 Holding Company, L.P. (the \"Reporting Person\"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share (\"Common Stock\"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share (\"Series B Preferred Stock\"), of MiMedx Group, Inc. (the \"Issuer\") held by Falcon Fund 2 Holding Company, L.P. (the \"Reporting Person\"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share (\"Common Stock\"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend."}],"balance_after":0,"derivative":{"exercise_price":3.85,"underlying":"Common Stock","underlying_shares":28195249},"source":{"system":"sec-edgar","filing":"0000950170-23-073331","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817718/000095017023073331/ownership.xml","form_type":"4"}},{"id":1699565,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":95804,"kind":"organization","name":"Falcon Fund 2 Holding Company, L.P.","position":1,"cik":"0001817718","reported_name":"Falcon Fund 2 Holding Company, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-12-27T16:47:43.000Z","date":"2023-12-22","kind":"exercise","planned":false,"acquired":true,"shares":28195249,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share (\"Series B Preferred Stock\"), of MiMedx Group, Inc. (the \"Issuer\") held by Falcon Fund 2 Holding Company, L.P. (the \"Reporting Person\"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share (\"Common Stock\"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share (\"Series B Preferred Stock\"), of MiMedx Group, Inc. (the \"Issuer\") held by Falcon Fund 2 Holding Company, L.P. (the \"Reporting Person\"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share (\"Common Stock\"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend."}],"balance_after":28195249,"source":{"system":"sec-edgar","filing":"0000950170-23-073331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817718/000095017023073331/ownership.xml","form_type":"4"}}]}